GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **326 - 350** of **4050** in total

« First

‹ Prev

…

10

11

12

13

14

15

16

17

18

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID ▼	Arbitrary Fluorescence Units (AFU)
IgM	Patient 3	11	mild	G92022ML	388
IgM	Patient 3	4	mild	G92022ML	252
IgA	Patient 4	12	mild	G92022ML	416
IgG	Patient 4	12	mild	G92022ML	58
IgM	Patient 4	12	mild	G92022ML	165
IgA	Patient 1	10	moderate	G91537AT	414
IgA	Patient 1	22	moderate	G91537AT	435
IgA	Patient 1	6	moderate	G91537AT	340
IgG	Patient 1	10	moderate	G91537AT	39
IgG	Patient 1	22	moderate	G91537AT	55
IgM	Patient 1	10	moderate	G91537AT	198
IgM	Patient 1	22	moderate	G91537AT	385
IgA	Patient 2	15	mild	G91537AT	404
IgA	Patient 2	24	mild	G91537AT	470
IgG	Patient 2	15	mild	G91537AT	1013
IgG	Patient 2	24	mild	G91537AT	957
IgM	Patient 2	15	mild	G91537AT	342
IgG	Patient 1	6	moderate	G91537AT	40
IgM	Patient 1	6	moderate	G91537AT	193
IgA	Patient 2	3	mild	G91537AT	469
IgG	Patient 2	3	mild	G91537AT	1537
IgM	Patient 2	24	mild	G91537AT	443
IgM	Patient 2	3	mild	G91537AT	462
IgA	Patient 3	-180	mild	G91537AT	283
IgA	Patient 3	11	mild	G91537AT	483